(NASDAQ: PRE) Prenetics Global's forecast annual revenue growth rate of 108.69% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 12.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 163.62%.
Prenetics Global's revenue in 2026 is $92,390,000.On average, 5 Wall Street analysts forecast PRE's revenue for 2026 to be $3,253,493,100, with the lowest PRE revenue forecast at $3,075,808,943, and the highest PRE revenue forecast at $3,467,456,549.
In 2027, PRE is forecast to generate $5,162,627,530 in revenue, with the lowest revenue forecast at $4,597,176,807 and the highest revenue forecast at $5,698,042,374.